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Abstract
Introduction Respiratory syncytial virus (RSV) bronchiolitis is
the most important cause for admission to the paediatric
intensive care unit in infants with lower respiratory tract infection.
In recent years the importance of extrapulmonary manifestations
of RSV infection has become evident. This systematic review
aimed at summarizing the available evidence on manifestations
of RSV infection outside the respiratory tract, their causes and
the changes in clinical management required.
Methods Databases searched were Medline (1950 to present),
EMBASE (1974 to present), PubMed and reference lists of
relevant articles. Summarized were the findings of articles
reporting on manifestations of RSV infection outside the
respiratory tract in patients of all age groups.
Results Extrapulmonary manifestations reported in previous
observational studies included cardiovascular failure with
hypotension and inotrope requirements associated with
myocardial damage as evident from elevated cardiac troponin
levels (35–54% of ventilated infants), cardiac arrhythmias like
supraventricular tachycardias and ventricular tachycardias,
central apnoeas (16–21% of admissions), focal and generalized
seizures, focal neurological abnormalities, hyponatraemia (33%)
associated with increased antidiuretic hormone secretion, and
hepatitis (46–49% of ventilated infants). RSV or its genetic
material have been isolated from cerebrospinal fluid,
myocardium, liver and peripheral blood.
Conclusion The data summarized indicate a systemic
dissemination of RSV during severe disease. Cerebral and
myocardial involvement may explain the association of RSV with
some cases of sudden infant death. In infants with severe RSV
infection cardiac rhythm, blood pressure and serum sodium
need to be monitored and supportive treatment including fluid
management adjusted accordingly.
Introduction
Respiratory syncytial virus (RSV) infection is the most common
cause of admission to the paediatric intensive care unit (PICU)
due to respiratory failure in infancy [1]. Together with influenza
virus, RSV is also the most common cause for admissions in
adults with chronic cardiac and pulmonary disorders and
acute respiratory failure [2]. Extrapulmonary presentations of
severe RSV infection were first highlighted in a report on an
epidemic affecting infants admitted to a children's hospital in
Cleveland (OH, USA). The authors described the features of a
'sepsis syndrome' and noted apnoeas in a significant propor-
tion of infants [3]. Carers need to be aware of manifestations
of RSV infection outside the respiratory tract because they
may result in otherwise unexpected deteriorations in their
patients. For staff looking after the patient with severe RSV
infection they may cause both diagnostic and management
problems. Awareness of effects of RSV infections outside the
respiratory tract are particularly important in managing patients
with known underlying comorbidities [2]. It is important to
know how much of an organ dysfunction is a temporary effect
of RSV or a sign of a deterioration of a pre-existing organ dis-
ease, for example in infants with congenital heart disease [4].
This systematic review aims at summarizing evidence on
extrapulmonary effects of RSV infection.
Methods
This systematic review summarizes the findings of articles
reporting on manifestations of RSV infection outside the respi-
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ratory tract. Included in the analysis were studies in patients of
all age groups with RSV infection. Excluded were studies on
manifestations that were not specific to RSV but were nonspe-
cific immunological effects of an acute viral infection. A study
including data on the influence of respiratory viral infections on
nephrotic syndrome [5] was therefore excluded. The data-
bases searched were Medline (1950 to present), EMBASE
(1974 to present) and PubMed. Keywords combined for data-
base search were the following: 'respiratory syncytial virus',
'RSV' and 'extrapulmonary', 'paediatric intensive care unit',
'pediatric intensive care unit', 'intensive therapy unit', 'intensive
care unit', 'myocardium', 'myocardial', 'arrhythmia', 'inotropes',
'shock', 'cardiac failure', 'hepatitis', 'apnoea', 'seizure', 'fit',
'hyponatremia', 'hyponatraemia' 'antidiuretic hormone', 'kid-
ney', 'CSF', 'cerebrospinal fluid'. Reference lists of relevant
articles were also searched.
Results
RSV and the cardiovascular system
The first report of clinically symptomatic myocardial involve-
ment during RSV bronchiolitis was that of a case of fatal inter-
stitial myocarditis in a child in 1972 [6]. Other early reports
include also the development of a second-degree heart block
during the disease. Subsequently a report of an RSV-associ-
ated multifocal atrial tachycardia appeared, a phenomenon
that was again reported in a later series of patients with RSV-
associated atrial tachycardias [7,8]. Other forms of supraven-
tricular tachycardias have also been reported during RSV
infection; they seemed to occur in patients with structurally
normal hearts and were not associated with hypoxia or beta-
agonist therapy [8,9]. Life-threatening arrhythmias have also
been reported. Atrial flutter was associated with cardiogenic
shock in one patient. This previously healthy patient had also
had long runs of ventricular tachycardia including torsades de
pointes. Ventricular fibrillation developed after an attempt at
overdrive pacing [10]. Another case of ventricular tachycardia
requiring cardioversion was reported subsequently [11].
Another life-threatening complication can be cardiac tampon-
ade evolving from pericardial effusion [10,12].
Cardiovascular compromise in the form of hypotension with-
out cardiac arrhythmias has also been described and has been
associated with evidence of myocardial damage as indicated
by elevated cardiac troponin I and T levels. Features of shock
have first been described in seven infants in an observational
study on 218 infants admitted to a children's hospital [3]. Ele-
vated cardiac troponin levels were found in 35 to 54% of
infants with RSV infection ventilated in PICUs [13,14]. Ele-
vated cardiac troponin I levels have also been found in children
with RSV infection not requiring mechanical ventilation [15].
The degree of cardiovascular support described ranged from
the administration of fluid boluses [14] to inotropic support
[13,16].
The first report on detection of RSV in the myocardium in
patients with bronchiolitis was in an infant with combined
immunodeficiency; the virus was cultured from myocardium
[17]. More recently RSV was again detected in the myocar-
dium by PCR in a patient with myocarditis [18].
Central nervous system manifestations of RSV
Acute neurological signs and symptoms such as central
apnoeas, seizures, lethargy, feeding or swallowing difficulties,
abnormalities of tone or strabism, abnormalities of the cerebro-
spinal fluid (CSF) or the electroencephalogram were found in
39% (n = 121) of RSV-positive patients on a PICU [19]. In a
population of RSV-positive patients admitted to the general
paediatric ward – that is, with milder disease and excluding
patients with simple febrile convulsions – neurological compli-
cations were found in 1.2% of patients (n = 964) [20]. Looking
at the occurrence of seizures as a manifestation of an enceph-
alopathy, another group found an incidence of seizures of
1.8% (n = 487) in patients with RSV bronchiolitis admitted to
a paediatric tertiary referral centre [21]. RSV was detected by
RT-PCR in the CSF of a four-month-old infant with apathy and
what seemed to be a febrile convulsion [22]. CSF abnormali-
ties were found in one study in 12 of 30 RSV patients who had
a lumbar puncture [19]. Other studies have found antibodies
specific for RSV in the CSF of patients with RSV bronchiolitis
[23,24].
Central apnoeas
Apnoeas defined as a respiratory arrest for more than 20 sec-
onds and/or bradycardia with accompanying cyanosis or oxy-
gen desaturation below 90% have been found in 16 to 21%
of children admitted to hospital with RSV infection [25]. The
most important risk factor associated with apnoeas was age
below two months. Apnoeas on admission increased the risk
for recurrent apnoeas, and these children did have a signifi-
cantly increased probability of requiring mechanical ventilation
[25]. A prospective experimental study in infants investigated
apnoea responses in infants with RSV infection. RSV-infected
infants were compared with non-infected infants with regard to
the reflex apnoea response to sterile water instilled into the
pharynx (laryngeal chemoreflex) during sleep. The data were
Table 1
Duration of apnoeas in response to the laryngeal chemoreflex 
in infants
Status Duration (s)
First apnoea Total apnoea Recovery time
RSV positive 5.0 ± 0.7a 10.9 ± 1.8a,b 38.0 ± 6.0a
RSV negative 3.1 ± 0.5 5.3 ± 1.0 21.0 ± 0.9
Controls 2.5 ± 0.4 3.4 ± 1.1 19.0 ± 5.0
The table is taken from [25], with the permission of Taylor & Francis.
Results are given as means ± SEM. RSV, respiratory syncytial virus; 
RSV negative, patients with RSV-negative bronchiolitis; controls, 
patients without respiratory tract infection. ap < 0.05 between RSV-
positive patients and controls; bp < 0.05 between RSV-positive 
patients and RSV-negative patients.Available online http://ccforum.com/content/10/4/R107
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put into relationship to nasopharyngeal levels of IL-1β and IL-
6. Both the duration of the first apnoea and the total apnoea
duration (all apnoeas) were significantly longer in patients with
RSV than in controls (see Table 1). There was a significant
negative correlation between nasopharyngeal IL-1β levels and
the duration of apnoea [26]. The apnoeas were not associated
with a higher level of pro-inflammatory cytokines.
Seizures
Seizure types found to be associated with RSV infection
include both generalized tonic–clonic and partial seizures with
altered consciousness and focal motor features or eye devia-
tion [19,20]. They were found in 0.7% (admissions to the
ward) to 6.6% (admissions to PICU) of patients. Some
patients presented with a status epilepticus [20]. Abnormali-
ties in the electroencephalogram have been noted in some
patients [19]. A cause of seizures in infants with RSV infection
previously identified is hyponatraemia [27] (see below under
endocrinological manifestations of RSV infection).
Other neurological manifestations
Strabismus has been reported as a neurological complication
in two large studies [19,20]. It was found in the form of
esotropia in four of 12 patients with neurological complica-
tions [20]. One case of acute axonal polyneuropathy [19] and
a case with features of encephalitis on imaging with magnetic
resonance imaging and positron emission tomography scan-
ning have also been described [28]. Diaphragmatic flutter
characterized by involuntary high-frequency contractions of
the diaphragm, occurring at a rate of 150 to 480 contractions
per minute asynchronous with the heartbeat, has been discov-
ered by chance on review of recordings from respiratory induc-
tive plethysmographs and impedance pneumographs in three
infants with RSV infection who were extensively monitored
because of concerns about apnoeas [29]. Diaphragmatic flut-
ter has been associated with inability to wean patients from
mechanical ventilation as well as with the need for assisted
ventilation in adults [30].
Endocrine effects of RSV bronchiolitis
Antidiuretic hormone
Hyponatraemia (a serum sodium level of less than 136 mmol/
l) was found in 33% of infants requiring intensive care with
RSV infection; 11% had a serum sodium level of less than 130
mmol/l [27]. In a less selected population of children, including
patients with milder disease, only 0.6% of patients had a
serum sodium level of less than 130 mmol/l [31]. This phe-
nomenon has prompted investigations into the underlying
endocrine causes. The first report on investigations of
hyponatraemia associated with RSV infection dealt with four
infants admitted to the ward with hyponatraemia and bronchi-
olitis during an outbreak of RSV. One presented with focal sei-
zures and hyponatraemia and was found to be RSV positive.
All four infants had elevated antidiuretic hormone (ADH) levels.
One had a synacthen test done, which showed normal cortisol
release [32]. Further investigations revealed that ADH levels
were significantly higher in patients with bronchiolitis than in
patients with apnoeas or upper respiratory tract infections with
RSV. The highest levels were found in patients receiving
mechanical ventilation [33]. Increased ADH levels were asso-
ciated with high arterial partial pressure of CO2 and hyperinfla-
tion on a chest X-ray. There was, however, no association
between ADH levels and serum sodium levels in this study.
Hyponatraemia and hyponatraemic seizures have in this con-
text been associated with the application of hypotonic fluids at
100 to 150 ml/kg per day [27].
Stress hormone responses
A prospective study comparing ventilated infants with RSV
infection and patients admitted to the ward showed that venti-
lated patients had higher prolactin and growth hormone levels
and significantly lower leptin and insulin-like growth factor-1
levels. Cortisol levels were not different. The leptin and prolac-
tin levels accounted for 57% of the variation in lymphocyte
count, which was significantly lower in ventilated patients with
RSV infection [34].
Respiratory syncytial virus-associated hepatitis
Elevated transaminase levels have been found in 46 to 49% of
ventilated children with RSV bronchiolitis [35,36]. Severe hep-
atitis with alanine aminotransferase levels of nearly 3,000 IU/l
has been noted and this was associated with coagulopathy
[35]. The peak of transaminase levels was found to be
between two and four days after admission (see Figure 1).
Respiratory disease, as judged by duration of ventilation, was
more severe in infants with elevated transaminase levels
[35,36]. The prevalence of hepatitis was 80% in children with
congenital heart disease. This was a significantly higher prev-
alence than the one found in children without congenital heart
disease [36]. Direct invasion of the liver in an immunocompe-
tent infant with RSV infection has been documented by the
Figure 1
Alanine aminotransferase (ALT) levels in infants with respiratory syncy- tial virus infection ventilated on a paediatric intensive care unit Alanine aminotransferase (ALT) levels in infants with respiratory syncy-
tial virus infection ventilated on a paediatric intensive care unit.Critical Care    Vol 10 No 4    Eisenhut 
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successful culture of RSV from material of a liver biopsy [37].
Hepatic involvement in the form of fatty changes was
described in a fatal case of Reye's syndrome associated with
RSV infection [38].
Other extrapulmonary manifestations of RSV 
bronchiolitis
Several other extrapulmonary manifestations of RSV infection
have been described but most of them only in single case
reports and none of them seem to be life threatening. They
include hypothermia [3], exanthems involving the trunk and
face in the form of a finely granular, scarlatiniform rash [3,39],
thrombocytopenia and conjunctivitis [40].
Supportive management of extrapulmonary 
manifestations of respiratory syncytial virus infection
Previous case series showed that RSV-associated ventricular
arrhythmias may respond to antiarrhythmic drugs such as lido-
caine and beta-blockers, and cardioversion [10]. Hypotension
may respond to simple fluid resuscitation [14] and, if this is not
successful, inotropic support for a few days [16].
Strategies used to treat RSV-associated apnoeas in previous
studies, none of which were randomized controlled trials,
included loading with caffeine, nasal continuous positive air-
way pressure, negative-pressure ventilation, and intubation
and mechanical ventilation [41,42]. Loading with caffeine sig-
nificantly reduced the frequency of apnoeas in seven infants
with RSV infection. Hyponatraemic seizures have been man-
aged successfully and safely by increasing the sodium levels
of less than 25 mmol/l over 48 hours (about 0.5 mmol/l per
hour). Hyponatraemic seizures may be resistant to anticonvul-
sive therapy and may require a more rapid correction by a 3%
saline bolus of 3 to 5 ml/kg followed by fluid restriction [27].
Hepatic involvement should prompt the clinician to investigate
for structural heart disease causing ischaemic hepatitis.
Discussion
Extrapulmonary manifestations suggest that RSV may infect
organs other than the lung. It is unlikely that systemic co-infec-
tion with bacterial pathogens is responsible for most extrapul-
monary manifestations. Previous studies have shown that
serious bacterial infection is present in 0.6 to 1.2% of children
admitted with RSV infection [43]. A previous study found that
in 63% of neonates and in 20% of infants with RSV detected
in nasopharyngeal aspirate on the PICU, RSV RNA was
detectable in peripheral blood by nested RT-PCR [44]. The
detection of RSV RNA in arterial blood (four infants with bron-
chiolitis) was also reported by another group [45]. These find-
ings demonstrate the way in which RSV is carried to
extrapulmonary sites. It can be postulated that apnoeas and
arrhythmias have led to unexpected deaths in infants with RSV
disease in the community, even though the detection of RSV
nucleic acid in postmortem tissue of infants who died of sud-
den infant death syndrome was not more common than in
infants who died from unrelated causes during the same time
period [46].
RSV and the cardiovascular system
Some of the authors of reports on arrhythmias or myocardial
failure in RSV infection doubted a direct role of the virus. As
highlighted in a previous report [47], right ventricular decom-
pensation due to pulmonary hypertension is a possible cause
for myocardial damage, cardiac troponin elevation and systolic
hypotension. Pulmonary disease is associated with pulmonary
hypertension in bronchiolitis [48]. Cardiac troponin T elevation
has previously been reported in patients with bacterial pneu-
monia [49]. Right ventricular strain may also precipitate
arrhythmias [50]. However, a direct involvement of RSV is sug-
gested by its isolation from myocardial tissue and the reported
occurrence of significant pericardial effusion.
RSV and the central nervous system
Apnoeas were the most common neurological manifestation of
RSV infection. A prospective experimental study looking at the
laryngeal chemoreflex [26] has clearly demonstrated that there
is an abnormal response at the level of the central nervous sys-
tem involved rather than that the apnoeas are secondary to
respiratory compromise or seizures alone. Detection of RSV in
the CSF has also supported a direct invasion of the central
nervous system in RSV disease.
RSV and the endocrine system
The lack of association of ADH levels with the reduced serum
sodium levels may be due to the associated hyperreninaemia
and features of secondary hyperaldoseronism leading to
sodium retention found in another study [51]. One can specu-
late that perceived hypovolaemia by intrathoracic receptors
may be involved. It seems that the development of hyponatrae-
mia requires the presence of both raised ADH levels and a
source of electrolyte-free water [27]. The study looking at the
neuroendocrine stress response found that, in keeping with
previous studies, lymphopenia is not related to increased cor-
tisol levels and provided new data on a possible relationship of
the low lymphocyte counts with increased prolactin and low
Table 2
Life-threatening extrapulmonary complications of severe 
infection with respiratory syncytial virus
Organs affected Complication References
Brain Apnoeas; status 
epilepticus
[19,20]
Heart Ventricular tachycardia; 
ventricular fibrillation; 
cardiogenic shock; 
complete heart block; 
pericardial tamponade
[7,10,12]
Brain, liver and 
kidney
Reye's syndrome [38]Available online http://ccforum.com/content/10/4/R107
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leptin levels. There is good evidence for a role of leptin in the
prevention of stress-induced apoptosis of T lymphocytes [52].
RSV and the liver
The higher prevalence of hepatitis in children with congenital
heart disease may indicate that hepatic venous congestion as
a result of right ventricular failure causing ischaemic hepatitis
may be involved in transaminase elevation in some of these
children. Apart from the documented direct invasion of the
liver, a possible effect of cytotoxic CD8-positive T lymphocytes
not requiring the presence of RSV itself has recently been
implicated in collateral damage to the liver in mild influenza
virus infection [53].
Agenda for future research
Future research needs to include randomized controlled trials
on the treatment of RSV-related central apnoeas by medica-
tion such as caffeine, which may be able to prevent the need
for mechanical ventilation. There is a lack of data on extrapul-
monary manifestations of RSV infection in the elderly where
co-morbidities such as ischaemic heart disease and cerebrov-
ascular insufficiency may put them at higher risk of their com-
plications. Future studies need to clarify how common
extrapulmonary manifestations such as arrhythmia and hepati-
tis are in patients with mild RSV infection. Long-term follow-up
case control studies, including detailed neuroimaging, of
infants with acute neurological manifestations of RSV infection
need to clarify whether there are potential long-term sequelae.
Conclusion
Extrapulmonary manifestations are common in ventilated
infants with severe RSV infection. This systematic review high-
lights that cardiac rhythm and blood pressure need to be mon-
itored carefully in these patients, to detect potentially life-
threatening complications (Table 2). Plasma sodium levels
need to be checked daily in patients requiring intravenous flu-
ids, and fluid input needs to be adjusted to avoid the develop-
ment of hyponatraemia and the associated seizures. These
requirements should be balanced against potential complica-
tions of invasive monitoring and overtreatment of infants with
RSV infection on the PICU, which have been found to be asso-
ciated with increases in costs and morbidity without improve-
ment in outcome [54].
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